Komori
Mitsubishi Research Institute (3636) · FactUpdated with interim R&D expenses

Research and development expenses of ¥278 million

First written in FY2017-Q2. . Latest entry: FY2026-H1.

30entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q2 – FY2026-H12017: 320172018: 320182019: 420192020: 420202021: 320212022: 320222023: 420232024: 420242025: 120252026: 1
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 191 companies write about · 0 as a headwind · 180 as a tailwind

45 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 191 companies compared. The sentences above are computed from all 191.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Updated with interim R&D expensesAnnual report

    「R&D expenses for the six-month interim consolidated accounting period were ¥483 million. There were no material changes in the status of R&D activities during the six-month interim consolidated accounting period.」

    The R&D expense results were updated from ¥1,710 million for the previous full fiscal year to ¥483 million for the six-month interim consolidated accounting period. It was stated that there were no material changes in the status of R&D activities.
  2. FY2025-H1Updated with interim R&D expensesAnnual report

    「R&D expenses for the six-month interim consolidated accounting period were ¥636 million. There were no material changes in the status of R&D activities during the six-month interim consolidated accounting period.」

    The R&D expense results were updated from ¥1,710 million for the full year to ¥636 million for the six months ended September 2024. It was stated that there were no material changes in the status of R&D activities.
  3. FY2024Updated to full-year research and development expensesAnnual report

    「R&D expenses for the current consolidated fiscal year were ¥1,710 million, including ¥1,141 million related to think-tank and consulting services and ¥569 million related to IT services.」

    The R&D expense results were updated from ¥1,736 million in the previous fiscal year to ¥1,710 million in the current fiscal year.
  4. FY2024-Q2Updated to second-quarter research and development expensesAnnual report

    「R&D expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥705 million. There were no material changes in the status of R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    The figures were updated from the first-quarter cumulative results to the second-quarter cumulative results, with R&D expenses at ¥705 million. It was stated that there were no material changes in the status of R&D activities.
  5. FY2024-Q1Updated to first-quarter research and development expensesAnnual report

    「R&D expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥293 million. There were no material changes in the status of R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」

    The results were updated from full-year R&D expenses of ¥1,736 million to R&D expenses of ¥293 million for the three months ended the first quarter of the current fiscal year. It was stated that there were no material changes in the status of R&D activities.
  6. FY2024-Q1Updated to first-quarter research and development expensesAnnual report

    「R&D expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥293 million. There were no material changes in the status of R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」

    The results were updated from full-year R&D expenses of ¥1,736 million to R&D expenses of ¥293 million for the three months ended the first quarter of the current fiscal year. It was stated that there were no material changes in the status of R&D activities.
  7. FY2023Updated to full-year research and development expensesAnnual report

    「R&D expenses for the current consolidated fiscal year were ¥1,736 million, including ¥1,246 million related to think-tank and consulting services and ¥489 million related to IT services.」

    The R&D expense results were updated from ¥1,265 million for the nine months ended the third quarter to ¥1,736 million for the full year.
  8. FY2023-Q3Updated to nine-month R&D expensesAnnual report

    「R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year were ¥1,265 million. There were no material changes in the status of R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」

    The R&D expense results were updated from ¥814 million for the six months ended the second quarter to ¥1,265 million for the nine months ended the third quarter, and it was stated that there were no material changes in the status of R&D activities.
  9. FY2023-Q2Updated to second-quarter research and development expensesAnnual report

    「R&D expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥814 million. There were no material changes in the status of R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    The figures were updated from the first-quarter cumulative results to the second-quarter cumulative results, with R&D expenses at ¥814 million. It was stated that there were no material changes in the status of R&D activities.
  10. FY2023-Q1Updated to first-quarter research and development expensesAnnual report

    「R&D expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥350 million. There were no material changes in the status of R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」

    The figures were updated from the nine-month cumulative results to the first-quarter cumulative results, with R&D expenses at ¥350 million. It was stated that there were no material changes in the status of R&D activities.
  11. FY2022-Q3Updated to nine-month R&D expensesAnnual report

    「R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year were ¥912 million. There were no material changes in the status of R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」

    The results were updated from R&D expenses of ¥505 million for the six months ended the second quarter to ¥912 million for the nine months ended the third quarter. It was stated that there were no material changes in the status of R&D activities.
  12. FY2022-Q2Updated to second-quarter research and development expensesAnnual report

    「R&D expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥505 million. There were no material changes in the status of R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    The figures were updated from the first-quarter cumulative results to the second-quarter cumulative results, with R&D expenses at ¥505 million. It was stated that there were no material changes in the status of R&D activities.
  13. FY2022-Q1Updated to first-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative first quarter were ¥189 million. There were no material changes in the status of research and development activities during the cumulative first quarter.」

    Updates from full-year and cumulative third-quarter actual results to research and development expenses of ¥189 million for the cumulative first quarter. States that there were no material changes in the status of research and development activities.
  14. FY2021-Q3Updated to nine-month R&D expensesAnnual report

    「Research and development expenses for the cumulative third quarter were ¥756 million. There were no material changes in the status of research and development activities during the cumulative third quarter.」

    Updates actual research and development expenses from ¥441 million for the cumulative second quarter to ¥756 million for the cumulative third quarter. States that there were no material changes in the status of research and development activities.
  15. FY2021-Q2Updated to second-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative second quarter were ¥441 million. There were no material changes in the status of research and development activities during the cumulative second quarter.」

    Updates actual research and development expenses from ¥157 million for the cumulative first quarter to ¥441 million for the cumulative second quarter, and states that there were no material changes in the status of research and development activities.
  16. FY2021-Q1Updated to first-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative first quarter were ¥157 million. There were no material changes in the status of research and development activities during the cumulative first quarter.」

    Updates actual research and development expenses to ¥157 million for the cumulative first quarter and states that there were no material changes in the status of research and development activities.
  17. FY2020Updated to full-year research and development expensesAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥1,041 million, comprising ¥834 million for the think tank and consulting services and ¥207 million for IT services.」

    Updated from research and development expenses of ¥801 million in the previous fiscal year to full-year actual research and development expenses of ¥1,041 million in the current fiscal year.
  18. FY2020-Q3Updated to nine-month R&D expensesAnnual report

    「Research and development expenses for the cumulative third quarter were ¥588 million. There were no material changes in the status of research and development activities during the cumulative third quarter.」

    Updates actual research and development expenses from ¥271 million for the cumulative second quarter to ¥588 million for the cumulative third quarter. States that there were no material changes in the status of research and development activities.
  19. FY2020-Q2Updated to second-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative second quarter were ¥271 million. There were no material changes in the status of research and development activities during the cumulative second quarter.」

    Updates actual research and development expenses from ¥111 million for the cumulative first quarter to ¥271 million for the cumulative second quarter. States that there were no material changes in the status of research and development activities.
  20. FY2020-Q1Updated to first-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative first quarter were ¥111 million. There were no material changes in the status of research and development activities during the cumulative first quarter.」

    Updates actual research and development expenses from ¥801 million for the full year to ¥111 million for the cumulative first quarter. States that there were no material changes in the status of research and development activities.
  21. FY2019Updated to full-year research and development expensesAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥801 million, comprising ¥616 million for the think tank and consulting services and ¥184 million for IT services.」

    Updates actual research and development expenses from ¥528 million for the cumulative third quarter to ¥801 million for the full year.
  22. FY2019-Q3Updated to nine-month R&D expensesAnnual report

    「Research and development expenses for the cumulative third quarter were ¥528 million. There were no material changes in the status of research and development activities during the cumulative third quarter.」

    Updates actual research and development expenses from ¥264 million for the cumulative second quarter to ¥528 million for the cumulative third quarter. States that there were no material changes in the status of research and development activities.
  23. FY2019-Q2Updated to second-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative second quarter were ¥264 million. There were no material changes in the status of research and development activities during the cumulative second quarter.」

    Updates actual research and development expenses from ¥118 million for the cumulative first quarter to ¥264 million for the cumulative second quarter. States that there were no material changes in the status of research and development activities.
  24. FY2019-Q1Updated to first-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative first quarter were ¥118 million. There were no material changes in the status of research and development activities during the cumulative first quarter.」

    Updates actual research and development expenses from ¥476 million for the cumulative third quarter to ¥118 million for the cumulative first quarter. States that there were no material changes in the status of research and development activities.
  25. FY2018-Q3Updated to nine-month R&D expensesAnnual report

    「Research and development expenses for the cumulative third quarter were ¥476 million. There were no material changes in the status of research and development activities during the cumulative third quarter.」

    Updates actual research and development expenses from ¥248 million for the cumulative second quarter to ¥476 million for the cumulative third quarter. States that there were no material changes in the status of research and development activities.
  26. FY2018-Q2Updated to second-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative second quarter were ¥248 million. There were no material changes in the status of research and development activities during the cumulative second quarter.」

    Updates actual research and development expenses from ¥83 million for the cumulative first quarter to ¥248 million for the cumulative second quarter, and states that there were no material changes in the status of research and development activities.
  27. FY2018-Q1Updated to first-quarter research and development expensesAnnual report

    「Research and development expenses for the cumulative first quarter were ¥83 million. There were no material changes in the status of research and development activities during the cumulative first quarter.」

    Updates actual research and development expenses from ¥930 million for the full year to ¥83 million for the cumulative first quarter, and states that there were no material changes in the status of research and development activities.
  28. FY2017Updated to full-year research and development expensesAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥930 million, and the main research and development activities by segment were as follows.」

    Updates actual research and development expenses from ¥567 million for the cumulative third quarter to ¥930 million for the full year.
  29. FY2017-Q3Updated to cumulative results for the third quarterAnnual report

    「Research and development expenses for the cumulative third quarter were ¥567 million. There were no material changes in the status of research and development activities during the cumulative third quarter.」

    Research and development expenses were updated from ¥278 million for the cumulative second quarter to ¥567 million for the cumulative third quarter, and the document states that there were no material changes in the status of research and development activities.
  30. FY2017-Q2First statedAnnual report

    「Research and development expenses for the cumulative second quarter were ¥278 million.」

    States that research and development expenses for the cumulative second quarter were ¥278 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mitsubishi Research Institute's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and development expenses of ¥278 million | Mitsubishi Research Institute,Inc. (3636) | Komori